R
Ronald Klein
Researcher at University of Wisconsin-Madison
Publications - 1306
Citations - 163459
Ronald Klein is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 194, co-authored 1305 publications receiving 149140 citations. Previous affiliations of Ronald Klein include Los Angeles Biomedical Research Institute & Wake Forest University.
Papers
More filters
Journal ArticleDOI
Using distance correlation and SS-ANOVA to assess associations of familial relationships, lifestyle factors, diseases, and mortality
TL;DR: This work builds a Smoothing Spline ANOVA model for predicting death age based on four major lifestyle factors generally known to be related to mortality and four major diseases contributing to mortality, to develop a lifestyle mortality risk vector and a disease mortality riskvector.
Journal ArticleDOI
Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study
Yao Liu,Nicholas J Zupan,Rebecca Swearingen,Nora Jacobson,Julia Carlson,Jane E. Mahoney,Ronald Klein,Timothy D. Bjelland,Maureen A. Smith +8 more
TL;DR: A model is developed that maps where key patient and PCP barriers occur in the teleophthalmology referral process and suggests system-based implementation strategies primarily targetingPCP barriers in conjunction with improved patient and provider education may increase telephthalmology use in rural, US multipayer primary care clinics.
Journal ArticleDOI
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes.
Massimo Porta,Iiro Toppila,Niina Sandholm,S. Mohsen Hosseini,Carol Forsblom,Kustaa Hietala,Lorenzo Borio,Valma Harjutsalo,Barbara E.K. Klein,Ronald Klein,Andrew D. Paterson,Per-Henrik Groop +11 more
TL;DR: Findings suggest that genetic variations in SLC19A3 play an important role in the pathogenesis of severe diabetic retinopathy and nephropathy and may explain why some individuals with type 1 diabetes are less prone than others to develop microvascular complications.
Journal ArticleDOI
Wisconsin Epidemiologic Study of Diabetic Retinopathy: XII. Relationship of C-Peptide and Diabetic Retinopathy
TL;DR: There was no relationship between higher levels of C-peptide and lower frequency of or less severe retinopathy within each group (younger onset using insulin, older onset using diabetes, and older onset not using insulin).
Journal ArticleDOI
A risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts.
Chung-Jung Chiu,Chung-Jung Chiu,Paul Mitchell,Ronald Klein,Barbara E.K. Klein,Min-Lee Chang,Gary Gensler,Allen Taylor,Allen Taylor +8 more
TL;DR: The MRSS was developed and validated to provide satisfactory accuracy and generalizability and may be used to screen patients at risk of developing advanced AMD.